Session » (2177–2194) Sjögren’s Syndrome – Basic & Clinical Science Poster II
- 9:00AM-11:00AM
-
Abstract Number: 2185
35 Years Follow-up of Primary Sjögren’s Disease: A Single Center Study
- 9:00AM-11:00AM
-
Abstract Number: 2193
Anti-citrullinated Protein Antibodies in Sjögren’s Syndrome Define a Subset of Patients with Lower B Cell Activation Markers and Higher Risk of Lung Involvement
- 9:00AM-11:00AM
-
Abstract Number: 2187
Association Between Illness Perception, Anxiety and Depression State, Disease Activity and Glucocorticoid Therapy in Patients with Sjӧgren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2194
Association of Self-perceived Oral Health Status with ESSPRI Reported by Sjögren’s Syndrome Patients
- 9:00AM-11:00AM
-
Abstract Number: 2177
Characterization of Crevicular Fluid Microbiota in Primary Sjögren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2184
Development of Salivary Gland Organoids to Study Sjögren Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2179
Disease Burden of Patients with Primary Sjögren’s Disease: Results from a Multinational Real-World Survey
- 9:00AM-11:00AM
-
Abstract Number: 2191
Efficacy of anti-CD38 Treatment with Daratumumab in Two Cases of Refractory and Severe Sjogren Disease
- 9:00AM-11:00AM
-
Abstract Number: 2183
Evolution of Lymphoma Predictors in Primary Sjogren’s Syndrome by Data Driven Analysis in Harmonized Patients
- 9:00AM-11:00AM
-
Abstract Number: 2178
Increased Risk of Dementia in Patients with Primary Sjogren’s Syndrome: A Nationwide Population-based Cohort Study
- 9:00AM-11:00AM
-
Abstract Number: 2188
Lung Cysts in Primary SS: New Findings on an Allegedly Innocuous Iiagnosis
- 9:00AM-11:00AM
-
Abstract Number: 2189
Lymphopenia Fluctuation Patterns Determine the Trajectory of the Disease in Sjogren’s Patients with Hematological Involvement
- 9:00AM-11:00AM
-
Abstract Number: 2182
Mitochondrial Alterations in Primary Sjögren´s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2186
Neurological Complications in Sjögren’s: Occurrence & Impact on Patient Quality of Life
- 9:00AM-11:00AM
-
Abstract Number: 2192
New Inducible Mouse Model of Sjögren’s Syndrome Represents a Valuable Tool to Assess the Impact of Gene Knockout on the Disease’s Physiopathology
- 9:00AM-11:00AM
-
Abstract Number: 2190
Saliclick: A Novel Technology for Minimal Invasive Salivary Gland Biopsy in Suspected Sjögren’s Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2180
Salivary and Plasma Mitochondrial Double-strand RNAs as a Diagnostic Biomarker for Sjӧgren Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 2181
Secretagogue Effect of PDE4 Inhibitor Apremilast on Human Salivary Gland Organoids Obtained from Primary Sjögren’s Syndrome Patients